Evidence map›Paper›PMID 39127052›Full record

ArticleJournal of the American Medical Informatics Association : JAMIA2024

PheMIME: an interactive web app and knowledge base for phenome-wide, multi-institutional multimorbidity analysis.

Siwei Zhang, Nick Strayer, Tess Vessels, Karmel Choi, Geoffrey W Wang, Yajing Li, Cosmin A Bejan, Ryan S Hsi, Alexander G Bick, Digna R Velez Edwards and 9 more

Abstract read
In one paragraph

Article in Journal of the American Medical Informatics Association : JAMIA, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Siwei ZhangDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, TN 37203, United States.ORCID 0009-0005-0873-5217
Nick StrayerPosit PBC, Boston, MA 02210, United States.
Tess VesselsDivision of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, United States.
Karmel ChoiPsychiatric & Neuro Developmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114, United States.
Geoffrey W WangDepartment of Statistics, North Carolina State University, Raleigh, NC 27695, United States.
Yajing LiDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, TN 37203, United States.
Cosmin A BejanDepartment of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN 37203, United States.
Ryan S HsiDepartment of Urology, Vanderbilt University Medical Center, Nashville, TN 37232, United States.
Alexander G BickDivision of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, United States.
Digna R Velez EdwardsDepartment of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, TN 37232, United States.
Michael R SavonaDivision of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, United States.
Elizabeth J PhillipsCenter for Drug Safety and Immunology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, United States.
Jill M PulleyVanderbilt Institute for Clinical and Translational Science, Vanderbilt University Medical Center, Nashville, TN 37203, United States.
Wesley H SelfVanderbilt Institute for Clinical and Translational Science, Vanderbilt University Medical Center, Nashville, TN 37203, United States.
Wilkins Consuelo HopkinsVanderbilt Institute for Clinical and Translational Science, Vanderbilt University Medical Center, Nashville, TN 37203, United States.
Dan M RodenDepartment of Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232, United States.
Jordan W SmollerPsychiatric & Neuro Developmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114, United States.
Douglas M RuderferDivision of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, United States.
Yaomin XuDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, TN 37203, United States.ORCID 0000-0002-3752-4006

Funding

Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7M
VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7M
The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
Pharmacogenomics of Arrhythmia TherapyU19HL065962 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RODEN, DAN M · 2010 to 2014
$17.4M
Understanding and preventing HLA-associated drug reactionsP50GM115305 · NIGMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PHILLIPS, ELIZABETH, RODEN, DAN M · 2015 to 2019
$13.0M
The Genetic Epemiology of Multiple SclerosisR01NS032830 · NINDS · VANDERBILT UNIVERSITY · PI HAINES, JONATHAN L · 1995 to 2010
$8.9M
Epidemiologic Architecture for Genes Linked to Environment (EAGLE)U01HG004798 · NHGRI · VANDERBILT UNIVERSITY · PI CRAWFORD, DANA C · 2008 to 2013
$8.8M
VESPA: Vanderbilt Electronic Systems for Pharmacogenomic AssessmentRC2GM092618 · NIGMS · VANDERBILT UNIVERSITY · PI DENNY, JOSHUA C., RODEN, DAN M · 2009 to 2010
$6.4M
Vanderbilt Genome Electronic Records ProjectU01HG006378 · NHGRI · VANDERBILT UNIVERSITY · PI RODEN, DAN M · 2011 to 2014
$4.0M
PsycheMERGE: Leveraging electronic health records and genomics for mental health researchR01MH118233 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI DAVIS, LEA K, SMOLLER, JORDAN W · 2019 to 2022
$3.1M
Understanding the genetic risk underlying racial disparities in uterine fibroids - Diversity SupplementR01HD074711 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI VELEZ EDWARDS, DIGNA R · 2013 to 2017
$2.9M
Automated Storage and Retrieval of Biological SystemsS10RR025141 · NCRR · VANDERBILT UNIVERSITY · PI RODEN, DAN M · 2008 to 2008
$988k
NCATS NIH HHS UL1 TR000445NCATS NIH HHS UL1 TR002243NCRR NIH HHS S10 RR025141NCRR NIH HHS UL1 RR024975NHGRI NIH HHS U01 HG004798NHGRI NIH HHS U01 HG006378NHLBI NIH HHS U19 HL065962NICHD NIH HHS R01 HD074711NIDDK NIH HHS R21 DK127075NIGMS NIH HHS P50 GM115305NIGMS NIH HHS RC2 GM092618NIHNIMH NIH HHS R01 MH118233NINDS NIH HHS R01 NS032830Shared Instrumentation S10RR025141The Vanderbilt University Medical Center dataset(s)UK Biobank Resource 43397Vanderbilt University Department of Biostatistics Development R21DK127075Vanderbilt University Department of Biostatistics Development Award R21DK127075Vanderbilt University Medical Center's SD/BioVU
6 · The paper itself

Abstract

objectivesTo address the need for interactive visualization tools and databases in characterizing multimorbidity patterns across different populations, we developed the Phenome-wide Multi-Institutional Multimorbidity Explorer (PheMIME). This tool leverages three large-scale EHR systems to facilitate efficient analysis and visualization of disease multimorbidity, aiming to reveal both robust and novel disease associations that are consistent across different systems and to provide insight for enhancing personalized healthcare strategies. MATERIALS AND

methodsPheMIME integrates summary statistics from phenome-wide analyses of disease multimorbidities, utilizing data from Vanderbilt University Medical Center, Mass General Brigham, and the UK Biobank. It offers interactive and multifaceted visualizations for exploring multimorbidity. Incorporating an enhanced version of associationSubgraphs, PheMIME also enables dynamic analysis and inference of disease clusters, promoting the discovery of complex multimorbidity patterns. A case study on schizophrenia demonstrates its capability for generating interactive visualizations of multimorbidity networks within and across multiple systems. Additionally, PheMIME supports diverse multimorbidity-based discoveries, detailed further in online case studies.

resultsThe PheMIME is accessible at https://prod.tbilab.org/PheMIME/. A comprehensive tutorial and multiple case studies for demonstration are available at https://prod.tbilab.org/PheMIME_supplementary_materials/. The source code can be downloaded from https://github.com/tbilab/PheMIME. DISCUSSION: PheMIME represents a significant advancement in medical informatics, offering an efficient solution for accessing, analyzing, and interpreting the complex and noisy real-world patient data in electronic health records.

conclusionPheMIME provides an extensive multimorbidity knowledge base that consolidates data from three EHR systems, and it is a novel interactive tool designed to analyze and visualize multimorbidities across multiple EHR datasets. It stands out as the first of its kind to offer extensive multimorbidity knowledge integration with substantial support for efficient online analysis and interactive visualization.

Indexed as

Electronic Health RecordsMultimorbidityHumansInternetKnowledge BasesPhenomicsPhenotypeSchizophreniaSoftwareUser-Computer Interfaceelectronic health records (EHRs)interactive network analysisinteroperability and reproducibilitymultimorbidityPheWASUK Biobank

Identifiers

PMID39127052
PMCPMC11491640

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.